Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 279

1.

Meta-analysis of the efficacy and tolerability of pramipexole versus ropinirole in the treatment of restless legs syndrome.

Quilici S, Abrams KR, Nicolas A, Martin M, Petit C, Lleu PL, Finnern HW.

Sleep Med. 2008 Oct;9(7):715-26. doi: 10.1016/j.sleep.2007.11.020. Epub 2008 Jan 28.

PMID:
18226947
2.

Randomized trials of dopamine agonists in restless legs syndrome: a systematic review, quality assessment, and meta-analysis.

Zintzaras E, Kitsios GD, Papathanasiou AA, Konitsiotis S, Miligkos M, Rodopoulou P, Hadjigeorgiou GM.

Clin Ther. 2010 Feb;32(2):221-37. doi: 10.1016/j.clinthera.2010.01.028. Review.

PMID:
20206780
3.

A mixed treatment comparison of gabapentin enacarbil, pramipexole, ropinirole and rotigotine in moderate-to-severe restless legs syndrome.

Sun Y, van Valkenhoef G, Morel T.

Curr Med Res Opin. 2014 Nov;30(11):2267-78. doi: 10.1185/03007995.2014.946124. Epub 2014 Jul 31.

PMID:
25050588
4.

Effect of ropinirole on sleep outcomes in patients with restless legs syndrome: meta-analysis of pooled individual patient data from randomized controlled trials.

Hansen RA, Song L, Moore CG, Gilsenan AW, Kim MM, Calloway MO, Murray MD.

Pharmacotherapy. 2009 Mar;29(3):255-62. doi: 10.1592/phco.29.3.255.

PMID:
19249945
6.

Pramipexole: in restless legs syndrome.

McCormack PL, Siddiqui MA.

CNS Drugs. 2007;21(5):429-37; discussion 438-40. Review.

PMID:
17447832
7.

Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study--the PRELUDE study.

Partinen M, Hirvonen K, Jama L, Alakuijala A, Hublin C, Tamminen I, Koester J, Reess J.

Sleep Med. 2006 Aug;7(5):407-17. Epub 2006 Jul 3.

PMID:
16815748
8.

Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study.

Inoue Y, Hirata K, Kuroda K, Fujita M, Shimizu T, Emura N, Uchimura N, Kagimura T, Sha K, Nozawa T.

Sleep Med. 2010 Jan;11(1):11-6. doi: 10.1016/j.sleep.2009.03.009. Epub 2009 Dec 4.

PMID:
19962941
9.

Long-term open-label study of pramipexole in patients with primary restless legs syndrome.

Inoue Y, Kuroda K, Hirata K, Uchimura N, Kagimura T, Shimizu T.

J Neurol Sci. 2010 Jul 15;294(1-2):62-6. doi: 10.1016/j.jns.2010.04.003. Epub 2010 May 7.

PMID:
20451927
10.

Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial.

Montplaisir J, Karrasch J, Haan J, Volc D.

Mov Disord. 2006 Oct;21(10):1627-35.

PMID:
16874755
12.

A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome.

Garcia-Borreguero D, Grunstein R, Sridhar G, Dreykluft T, Montagna P, Dom R, Lainey E, Moorat A, Roberts J.

Sleep Med. 2007 Nov;8(7-8):742-52. Epub 2007 May 18.

PMID:
17512789
13.

Open-label study of the long-term efficacy and safety of pramipexole in patients with Restless Legs Syndrome (extension of the PRELUDE study).

Partinen M, Hirvonen K, Jama L, Alakuijala A, Hublin C, Tamminen I, Koester J, Reess J.

Sleep Med. 2008 Jul;9(5):537-41. doi: 10.1016/j.sleep.2007.12.004. Epub 2008 Feb 13.

PMID:
18276187
14.

Ropinirole: new indication. Restless legs: disproportionate adverse effects.

[No authors listed]

Prescrire Int. 2006 Oct;15(85):173-6.

PMID:
17128523
15.

Ropinirole for restless legs syndrome: a placebo-controlled crossover trial.

Adler CH, Hauser RA, Sethi K, Caviness JN, Marlor L, Anderson WM, Hentz JG.

Neurology. 2004 Apr 27;62(8):1405-7.

PMID:
15111683
16.

Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study.

Walters AS, Ondo WG, Dreykluft T, Grunstein R, Lee D, Sethi K; TREAT RLS 2 (Therapy with Ropinirole: Efficacy And Tolerability in RLS 2) Study Group.

Mov Disord. 2004 Dec;19(12):1414-23.

PMID:
15390050
17.

Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial.

Ferini-Strambi L, Aarskog D, Partinen M, Chaudhuri KR, Sohr M, Verri D, Albrecht S.

Sleep Med. 2008 Dec;9(8):874-81. doi: 10.1016/j.sleep.2008.09.001. Epub 2008 Oct 25.

PMID:
18952497
18.

Efficacy of pramipexole in restless legs syndrome: a six-week, multicenter, randomized, double-blind study (effect-RLS study).

Oertel WH, Stiasny-Kolster K, Bergtholdt B, Hallström Y, Albo J, Leissner L, Schindler T, Koester J, Reess J; Pramipexole RLS Study Group.

Mov Disord. 2007 Jan 15;22(2):213-9.

PMID:
17133582
19.

Clinical efficacy of ropinirole for restless legs syndrome is not affected by age at symptom onset.

Allen RP, Ritchie SY.

Sleep Med. 2008 Dec;9(8):899-902. Epub 2007 Nov 19.

PMID:
18024167
20.

Efficacy and safety of pramipexole in chinese patients with restless legs syndrome: results from a multi-center, randomized, double-blind, placebo-controlled trial.

Ma JF, Wan Q, Hu XY, Sun SG, Wang WZ, Zhao ZX, Wang YJ, Liu CF, Li JM, Jiang YP, Chen SD.

Sleep Med. 2012 Jan;13(1):58-63. doi: 10.1016/j.sleep.2011.03.021. Epub 2011 Dec 3.

PMID:
22137119

Supplemental Content

Support Center